IOVA FY 2019 Earnings — Iovance Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

IOVAIovance Biotherapeutics, Inc.

$2B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$8M

Operating Income

-$207M

Net Income

-$198M

EPS (Diluted)

$-1.50

Cash Flow

Operating Cash Flow

-$159M

Free Cash Flow

-$166M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$345M

Total Liabilities

$46M

Stockholders' Equity

$299M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$8M	-$956,000	-749.7%
Operating Income	-$207M	-$128M	-61.3%
Net Income	-$198M	-$124M	-59.9%